• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultrasound BI-RADS might need some fine-tuning

Article

Breast cancers missed by mammography could have been misclassified as benign lesions by ultrasound to begin with, according to a study presented at the American Institute of Ultrasound in Medicine meeting in Orlando in June.

Breast cancers missed by mammography could have been misclassified as benign lesions by ultrasound to begin with, according to a study presented at the American Institute of Ultrasound in Medicine meeting in Orlando in June.

Dr. Dona J. Hills and colleagues from the Queens-Long Island Medical Group in New York found that 41 cancers matched current BI-RADS 2 and 3 assignments, based on their original ultrasound descriptions. They also found that 23 of the 41 had benign or negative findings on mammography. Physicians should be suspicious about ultrasound-detected lesions with atypical features, which can cause false negatives in mammography as well, Hills said.

"If we exclude suspicious findings from the 'probably benign' category and put them into a BI-RADS 4, we might not be underestimating as many cancers as we had underestimated before," she said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.